Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/18/2025

Management of Multiple System Atrophy

Non-Pharmacological Interventions

  • The American Heart Association recommends acute water ingestion (240-480 mL) for temporary relief of orthostatic hypotension, with peak effect occurring 30 minutes after ingestion 1
  • Physical counter-pressure maneuvers, such as leg crossing, lower body muscle tensing, and maximal force handgrip, can help alleviate orthostatic hypotension 1
  • Compression garments (at least thigh-high, preferably including abdomen) can help improve blood pressure in patients with orthostatic hypotension 1
  • Increased salt and fluid intake (6-9g salt per day) can help increase blood volume, unless contraindicated by hypertension, renal disease, or heart failure 1

Pharmacological Interventions

  • Midodrine is a first-line pharmacological therapy for orthostatic hypotension, with a dose-dependent effect that increases standing blood pressure 1
  • Droxidopa is particularly effective for neurogenic orthostatic hypotension in MSA patients 1
  • Fludrocortisone can increase plasma volume, but should be used with caution if supine hypertension is present 1
  • Pyridostigmine and Octreotide may be used for patients refractory to other treatments for orthostatic hypotension 1

Diagnostic Evaluation

  • The American College of Radiology recommends MRI Brain as the optimal imaging modality for MSA diagnosis, with 3T MRI preferable over 1.5T for better resolution 2, 3
  • MRI findings that support MSA diagnosis include:

    Finding MSA Type
    Putaminal atrophy, hypointensity on T2-weighted images, "hot cross bun" sign MSA-P
    Cerebellar and pontine atrophy, middle cerebellar peduncle hyperintensity MSA-C

    2

  • Ioflupane SPECT/CT (DaTscan) demonstrates decreased radiotracer uptake in the striatum, but cannot differentiate MSA from other parkinsonian syndromes 2
  • Cardiovascular autonomic testing, urodynamic studies, and sudomotor function tests can help document orthostatic hypotension and evaluate bladder dysfunction in MSA patients 2
  • Advanced MRI techniques, such as diffusion tensor imaging and voxel-based morphometry, may aid in MSA diagnosis, as well as fluid biomarkers, skin biopsy, and retinal imaging biomarkers 3

Monitoring and Disease Management

  • Regular monitoring of blood pressure (lying and standing) is essential for managing orthostatic hypotension 1
  • Supine hypertension is a common side effect of medications used to treat orthostatic hypotension and requires careful monitoring 1
  • The disease typically progresses faster than Parkinson's disease, with median survival of approximately 9.5 years from symptom onset 1
  • Main differential diagnoses to consider in MSA include Parkinson's disease, Progressive supranuclear palsy (PSP), Corticobasal degeneration (CBD), Pure autonomic failure, Spinocerebellar ataxias, and Vascular parkinsonism 2